
Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease
- Author
- Eva Gijbels (UGent) , Kevin De Muynck (UGent) , Bart Vanderborght (UGent) , Tim Meese (UGent) , Filip Van Nieuwerburgh (UGent) , Aude Vanlander, Frederik Berrevoet (UGent) , Bart Hendrikx (UGent) , Anne Hoorens (UGent) , Hans Van Vlierberghe (UGent) , Mathieu Vinken and Lindsey Devisscher (UGent)
- Organization
- Keywords
- Cell Biology, Genetics (clinical), Molecular Biology, Biochemistry
Downloads
-
published version.pdf
- full text (Published version)
- |
- open access
- |
- |
- 684.54 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01H41CDAG8MV5N0FD79Q0GGTKW
- MLA
- Gijbels, Eva, et al. “Systematic Comparison of Experimental and Human Obstructive Cholestasis Reveals Conservation of Canonical Pathway Activation and Biomarkers Relevant for Cholestatic Liver Disease.” GENES & DISEASES, vol. 10, no. 1, Elsevier BV, 2023, pp. 18–21, doi:10.1016/j.gendis.2022.02.003.
- APA
- Gijbels, E., De Muynck, K., Vanderborght, B., Meese, T., Van Nieuwerburgh, F., Vanlander, A., … Devisscher, L. (2023). Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease. GENES & DISEASES, 10(1), 18–21. https://doi.org/10.1016/j.gendis.2022.02.003
- Chicago author-date
- Gijbels, Eva, Kevin De Muynck, Bart Vanderborght, Tim Meese, Filip Van Nieuwerburgh, Aude Vanlander, Frederik Berrevoet, et al. 2023. “Systematic Comparison of Experimental and Human Obstructive Cholestasis Reveals Conservation of Canonical Pathway Activation and Biomarkers Relevant for Cholestatic Liver Disease.” GENES & DISEASES 10 (1): 18–21. https://doi.org/10.1016/j.gendis.2022.02.003.
- Chicago author-date (all authors)
- Gijbels, Eva, Kevin De Muynck, Bart Vanderborght, Tim Meese, Filip Van Nieuwerburgh, Aude Vanlander, Frederik Berrevoet, Bart Hendrikx, Anne Hoorens, Hans Van Vlierberghe, Mathieu Vinken, and Lindsey Devisscher. 2023. “Systematic Comparison of Experimental and Human Obstructive Cholestasis Reveals Conservation of Canonical Pathway Activation and Biomarkers Relevant for Cholestatic Liver Disease.” GENES & DISEASES 10 (1): 18–21. doi:10.1016/j.gendis.2022.02.003.
- Vancouver
- 1.Gijbels E, De Muynck K, Vanderborght B, Meese T, Van Nieuwerburgh F, Vanlander A, et al. Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease. GENES & DISEASES. 2023;10(1):18–21.
- IEEE
- [1]E. Gijbels et al., “Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease,” GENES & DISEASES, vol. 10, no. 1, pp. 18–21, 2023.
@article{01H41CDAG8MV5N0FD79Q0GGTKW, author = {{Gijbels, Eva and De Muynck, Kevin and Vanderborght, Bart and Meese, Tim and Van Nieuwerburgh, Filip and Vanlander, Aude and Berrevoet, Frederik and Hendrikx, Bart and Hoorens, Anne and Van Vlierberghe, Hans and Vinken, Mathieu and Devisscher, Lindsey}}, issn = {{2352-4820}}, journal = {{GENES & DISEASES}}, keywords = {{Cell Biology,Genetics (clinical),Molecular Biology,Biochemistry}}, language = {{eng}}, number = {{1}}, pages = {{18--21}}, publisher = {{Elsevier BV}}, title = {{Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease}}, url = {{http://doi.org/10.1016/j.gendis.2022.02.003}}, volume = {{10}}, year = {{2023}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: